SYMPHONIE - A comparison of Symbicort Single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults
Study identifier:D5890L00005
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A comparison of Symbicort Single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults – a 26-week, randomised, open, parallel group multicentre study
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
Budesonide/formoterol Turbuhaler
Sex
All
Actual Enrollment
1000
Study type
Interventional
Age
12 Years +
Date
Study Start Date: 01 Sept 2004
Primary Completion Date: -
Study Completion Date: 01 Jan 2006
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca France Medical Director
AstraZeneca
